Stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumors: The RAPPORT trial.

277Background: Pembrolizumab monotherapy, whilst not standard of care, has demonstrated efficacy in clear cell renal cell carcinoma (ccRCC). The first-line KEYNOTE-427 study demonstrated an overall...